Drug Approval | September 06, 2021
Alembic JV Aleor receives US FDA final approval for skin disorder gel
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP are available in one strength of 5 mg/2.5 mg capsules in bottle count sizes of 100
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
Zydus was the first to file an ANDA for Tofacitinib extended-release tablets 22 mg and currently holds 180-day exclusivity on this strength
Enoxaparin Sodium Injection, USP is used for prophylaxis of Deep Vein Thrombosis (DVT) in patients undergoing abdominal, hip or knee replacement surgery, and also for the treatment of acute DVT
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21
It’s an AB-rated generic therapeutic version of Durezol
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
It had an estimated market size of US $ 32 million as of June 2021
Subscribe To Our Newsletter & Stay Updated
